共查询到17条相似文献，搜索用时 140 毫秒
1.
2.
3.
4.
为评价水貂犬瘟热Vero细胞活疫苗(CDV3-CL株,悬浮培养)冻干制剂在临床应用中的安全性和免疫效果,分别在吉林、辽宁两省选择饲养规模相似的3个毛皮兽场进行疫苗安全性(10头份)和免疫效力实验(1头份)研究,接种后观察动物的临床症状,检测抗体水平并随机选择部分水貂进行攻毒试验。结果显示,超剂量接种水貂未见有明显的临床症状,对水貂的生产性能无明显影响;水貂免疫疫苗后21 d即可获得达到免疫保护的抗体水平;免疫180 d仍能维持较高水平的抗体,且能够保护动物抵抗强毒攻击。试验表明,水貂犬瘟热Vero细胞活疫苗(CDV3-CL株,悬浮培养)冻干制剂具有较好的临床保护效果。 相似文献
5.
6.
7.
8.
水貂肠炎病毒高免卵黄抗体的制备及应用 总被引：2，自引：0，他引：2
用水貂肠炎病毒免疫蛋鸡制备卵黄抗体,结果表明,经５次免疫制备的卵黄抗体,于最后一次免疫第１０天ＡＧＰ效价达１：３２,第３０天效价为１：８。该抗体较稳定。４℃保存１２０天,－２０℃保存１８０天效价不变。用该抗体治疗细小病毒肠炎病犬,治愈率达９３．９％,证实用水貂肠炎病毒制备卵黄抗体是成功的,可用于国小病毒肠炎的治疗。 相似文献
9.
10.
本研究旨在探索水貂肠炎病毒（mink enteritis virus,MEV）的母源抗体消长规律及其亚单位疫苗免疫效果。以免疫母貂所生仔貂为研究对象,采集21、30、45、60日龄仔貂血清,测定水貂病毒性肠炎母源抗体HI效价（MEV HI）;选取25只47~52日龄健康水貂接种制备MEV基因工程亚单位疫苗,免疫前后14 d采血测定MEV HI效价;免疫后14 d进行水貂肠炎病毒攻毒临床症状观察,并测定粪便HA效价;攻毒后14 d对濒死和存活水貂安乐死,采集十二指肠、空肠和回肠进行病理组织学观察和免疫组化检测。结果显示,免疫母貂所产仔貂的MEV HI效价随着日龄的增加逐渐降低,在21日龄时较高,45日龄时少部分仔貂MEV HI效价<1：32,60日龄时大部分仔貂HI效价≤ 1：4;使用制备合格疫苗免疫后14 d对照组水貂的MEV HI效价均不高于1：4,免疫组MEV HI效价升高至1：64~1：512;攻毒保护试验表明,免疫组水貂100%抵抗水貂肠炎病毒强毒的攻击,水貂的精神、饮食、粪便等均未见异常,且攻毒后粪便HA效价为1：8~1：16;病理组织学和免疫组化检测结果表明,MEV基因工程亚单位疫苗能够很好地阻止病毒在肠黏膜上皮细胞的复制和对肠黏膜上皮细胞的损伤。因此,免疫母貂所生仔貂21日龄时体内抗体效价最高,制备的疫苗免疫50日龄左右的水貂时能够突破母源抗体干扰并产生高水平的抗体,能够抵抗水貂肠炎病毒强毒株的攻击。 相似文献
11.
白细胞介素-2对犬细小病毒疫苗免疫效果的影响 总被引：3，自引：2，他引：1
为研究白细胞介素-2(IL-2)对犬细小病毒疫苗免疫效果的影响,选择40只幼犬,随机分成试验组和对照组,试验组按0.5 ml/头份加入犬用IL-2与犬细小病毒疫苗一起皮下注射,对照组单独使用犬细小病毒疫苗,注射后分别在接种前、接种后7 d和14 d使用金标试纸条检测其抗体效价,并进行组间抗体效价差异的t检验。试验结果表明,接种疫苗前试验组与对照组犬细小病毒平均抗体效价之间差异不显著;接种疫苗后7 d,试验组与对照组犬细小病毒平均抗体效价差异极显著(P<0.01);接种疫苗后14 d,试验组与对照组犬细小病毒平均抗体效价差异极显著(P<0.01)。试验表明:IL-2可明显提高幼犬对犬细小病毒疫苗的抗体应答能力,是一种良好的犬细小病毒疫苗候选佐剂。 相似文献
12.
Response of mink, skunk, red fox and raccoon to inoculation with mink virus enteritis, feline panleukopenia and canine parvovirus and prevalence of antibody to parvovirus in wild carnivores in Ontario. 
下载免费PDF全文
下载免费PDF全文 Mink virus enteritis, feline panleukopenia and canine parvovirus-2 were inoculated separately into groups of raccoon, mink, red fox and striped skunk. Raccoons were highly susceptible to mink virus enteritis and feline panleukopenia, with animals developing clinical illness, and several dying within six to ten days of inoculation with lesions typical of parvovirus infection. Both viruses were shed in high titre in the feces of infected raccoons, and high antibody titres were stimulated. Raccoons inoculated with canine parvovirus-2 showed no signs; shedding of virus was sporadic though moderate titres of antibody developed. Mink inoculated with mink virus enteritis and feline panleukopenia developed signs and lesions of early parvovirus infection. No signs or significant lesions followed canine parvovirus-2 inoculation. Shedding of virus was heavy (mink virus enteritis) or sporadic (feline panleukopenia and canine parvovirus-2), though good serological responses were elicited to all three viruses. Red fox showed no signs of infection, shed all three viruses only sporadically, and the serological response was strong only to feline panleukopenia. Skunks developed low antibody titres, but no signs, and did not shed virus. Antibody to parvovirus was found in 79.2% of 144 wild red foxes; 22.3% of 112 wild raccoons; 1.3% of 157 wild skunks and 6/7 coyotes in southern Ontario. The likely significance of these viruses to wild and captive individuals and populations of these carnivores is discussed. 相似文献
13.
为研究白细胞介素 2（IL-2）对犬细小病毒疫苗免疫效果的影响,选择40只幼犬,随机分成试验组和对照组,试验组按0.5 ml/头份加入犬用IL-2与犬细小病毒疫苗一起皮下注射,对照组单独使用犬细小病毒疫苗,注射后分别在接种前、接种后7 d和14 d使用金标试纸条检测其抗体效价,并进行组间抗体效价差异的t检验。试验结果表明,接种疫苗前试验组与对照组犬细小病毒平均抗体效价之间差异不显著;接种疫苗后7 d,试验组与对照组犬细小病毒平均抗体效价差异极显著(P<0.01);接种疫苗后14 d,试验组与对照组犬细小病毒平均抗体效价差异极显著(P<0.01)。试验表明：IL 2可明显提高幼犬对犬细小病毒疫苗的抗体应答能力,是一种良好的犬细小病毒疫苗候选佐剂。 相似文献
14.
WU Hongchao WANG Lingxiao HUO Ningning DING Hangtian CHEN Yalei XI Xiangfeng LIU Youcai LIU Yuxiu TIAN Kegong 《中国畜牧兽医》2007,47(11):3705-3712
The purpose of this study was to investigate the dynamic of mink enteritis virus (MEV) maternal antibody and the immune effects of subunit vaccines.The offspring of immunized female mink were studied,serum of 21,30,45 and 60 days old mink were collected to determine the HI titer of maternal antibody of MEV.25 healthy minks aged 47~52 days were selected to be inoculated with MEV genetic engineering subunit vaccine,and then blood samples were collected 14 d before and after immunization to determine MEV HI titer.The clinical symptoms and the titer of feces HA of mink enteritis virus were observed 14 d after immunization.Dying and surviving minks were euthanized 14 d after challenge,the duodenum,jejunum and ileum were collected for histopathological observation and immunohistochemical detection.The results showed that the MEV HI of the offspring of immunized female mink decreased gradually with the increase of day age,it was higher at 21 d of age,the MEV HI titer of some minks at 45 d was <1:32 and ≤ 1:4 at 60 d.The MEV HI titer of the control mink was not higher than 1:4 on 14 d after the preparation of qualified vaccine,while it was increased to 1:64~1:512 in immune group.Challenge protection tests showed that the immuned minks were 100% resistant to the attack of mink enteritis virus,and there was no abnormality in the mink's mental state,diet and feces,the HA titer of feces matter after challenge was 1:8~1:16.Histopathological and immunohisto-chemical tests showed that MEV genetic engineering subunit vaccine could well prevent the replication of virus in intestinal mucosal epithelial cells and the damage to intestinal epithelial cells.Therefore,the antibody titer was highest at 21 day-old after immunizing female mink,and the prepared vaccine could break through maternal antibody interference and produce high levels of antibodies when it immunized minks at about 50 d of age,and could resist the attack of mink enteritis virus virulent strain. 相似文献
15.
16.
健康水貂6只,3只作对照,另3只口服-20℃保存9个月的水貂细小病毒性肠炎粪毒。实验貂临床症状典型,小肠粘膜出现“气球样”上皮细胞,肠腺和绒毛上皮细胞广泛变性、坏死、脱落,胞浆内可见嗜酸性小体;胞核可见两种类型Cowdry A型包涵体;在肠系膜淋巴结、骨髓、脾和肾上腺也观察到了核内包涵体。在小肠绒毛上皮细胞膜上和肠腺腺腔中发现大量G-小杆菌。同时,用扫描电镜观察了各肠段粘膜表面的变化;用透射电镜研究了空肠前段粘膜上皮细胞中水貂细小病毒(MPV)的形态发生及其所引起的超微病变,发现核仁及其相随染色质参与了核内包涵体的形成。 相似文献
17.
van Heerden J Bingham J van Vuuren M Burroughs RE Stylianides E 《Journal of the South African Veterinary Association》2002,73(1):8-12
Wild dogs Lycaon pictuis (n = 8) were vaccinated 4 times against canine distemper (n = 8) (initially with inactivated and subsequently with live attenuated strains of canine distemper) and canine parvovirus infection (n = 8) over a period of 360 days. Four of the wild dogs were also vaccinated 3 times against rabies using a live oral vaccine and 4 with an inactivated parenteral vaccine. Commercially-available canine distemper, canine parvovirus and parenteral rabies vaccines, intended for use in domestic dogs, were used. None of the vaccinated dogs showed any untoward clinical signs. The inactivated canine distemper vaccine did not result in seroconversion whereas the attenuated live vaccine resulted in seroconversion in all wild dogs. Presumably protective concentrations of antibodies to canine distemper virus were present in all wild dogs for at least 451 days. Canine parvovirus haemagglutination inhibition titres were present in all wild dogs prior to the administration of vaccine and protective concentrations persisted for at least 451 days. Vaccination against parvovirus infection resulted in a temporary increase in canine parvovirus haemagglutination inhibition titres in most dogs. Administration of both inactivated parenteral and live oral rabies vaccine initially resulted in seroconversion in 7 of 8 dogs. These titres, however, dropped to very low concentrations within 100 days. Booster administrations resulted in increased antibody concentrations in all dogs. It was concluded that the vaccines were safe to use in healthy subadult wild dogs and that a vaccination protocol in free-ranging wild dogs should at least incorporate booster vaccinations against rabies 3-6 months after the first inoculation. 相似文献